Paul Mehlhop is a Rheumatology/Immunology physician affiliated with East Carolina University. OpenAlex indexes 9 publications with 850 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2395 Hemby Ln.
Greenville, NC 27834
Telephone
252-321-8683Registry record last updated 28 Jan 2010.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Organon LLCProgram year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
94.6%Leukotriene Receptor Antagonist35.9%Montelukast Sodium100%Part D≥71 patientsCorticosteroid23.8%Fluticasone Propionate52%Fluticasone Propionate Hfa17%Symbicort11%Trelegy Ellipta8%Arnuity Ellipta7%Qnasl6%Part D<11 patients+ 4 more classes in this area
Nervous system
3.1%Tricyclic Antidepressant1.6%Doxepin Hcl100%Part D<11 patientsAntihistamine1.5%Hydroxyzine Hcl100%Part D<11 patientsMetabolism & gastrointestinal
2.3%Corticosteroid2.3%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Erythropoietin ameliorates chemotherapy‐induced fibrosis of the lungs in a preclinical murine model
International Journal of Cancer
2008 - Impact of inadequately controlled asthma: a need for targeted therapy?*
Journal of Clinical Pharmacy and Therapeutics
2004 - IL-4 production in response to allergen stimulation and clinical symptoms of allergic rhinitis
Journal of Allergy and Clinical Immunology
2002 - CD40L, but Not CD40, Is Required for Allergen-Induced Bronchial Hyperresponsiveness in Mice
American Journal of Respiratory Cell and Molecular Biology
2000 - 462 High doses of dust mite allergen, dermatophagoides farinae, inhibit bronchoalveolar eosinophilia and diminish Th2 cytokine expression in vitro
Journal of Allergy and Clinical Immunology
2000
Similar KOLs
Other experts from the same institution or the same specialty.
Blase Carabello
East Carolina University
Hans Tillmann, MD
East Carolina University
Emmanuel Zervos, MD
East Carolina University
Emil Missov, MD
East Carolina University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”